EMERYVILLE, Calif.,
Sept. 14, 2020 /PRNewswire/
-- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic
biotechnology company in Clean Health and Beauty markets through
its consumer brands, and a top supplier of sustainable and natural
ingredients, today announced that John
Melo, President and Chief Executive Officer, will provide a
business overview and update on current affairs during the H.C.
Wainwright 22nd Annual Global Investment Virtual Conference today.
The company will also be participating in virtual one-on-one
meetings during the conference.
The company's presentation is at 10:00
a.m. ET today. A live webcast of the presentation
including slides and a replay will be available on the investor
relations section of the company's website at
http://investors.amyris.com. Due to the format of the virtual
conference, no audience question and answer session will be
available.
About Amyris
Amyris (Nasdaq: AMRS) is a science and
technology leader in the research, development and production of
sustainable ingredients for the Clean Health & Beauty and
Flavors & Fragrances markets. Amyris uses an impressive array
of exclusive technologies, including state-of-the-art machine
learning, robotics and artificial intelligence. Our ingredients are
included in over 3,000 products from the world's top brands,
reaching more than 200 million consumers. Amyris is proud to own
three consumer brands - all built around its No Compromise® promise
of clean ingredients: Biossance™ clean beauty skincare, Pipette™
clean baby skincare and Purecane™, a zero-calorie sweetener
naturally derived from sugarcane. For more information, please
visit www.amyris.com.
Amyris, the Amyris logo, No Compromise, Biossance, Pipette, and
Purecane are trademarks or registered trademarks of Amyris, Inc. in
the U.S. and/or other countries.
View original content to download
multimedia:http://www.prnewswire.com/news-releases/amyris-to-provide-business-overview-and-update-on-current-affairs-at-hc-wainwright-22nd-annual-global-investment-conference-today-301129839.html
SOURCE Amyris, Inc.